Archives

img-01

Korea Improving Drug Reimbursement

As mentioned in our July Pacific Bridge Newsletter, Korea plans to increase drug reimbursement for innovative, cancer and rare disease drugs. This reimbursement increase has been confirmed in the recently released Seoul National University R&DB Research Foundation report.  In addition to better... Read More

img-01

Taiwan Looks to Reduce Drug Prices

Taiwan is Asia’s 6th largest drug market with many Western drug companies selling their products there. However, similar to many other drug markets around the world, Taiwan wants to reduce drug prices and government health expenditures. Accordingly, in mid-September, Taiwan’s National Health... Read More

img-01

Hong Kong Joins ICH as an Observer

Last month, PBM’s newsletter outlined how Hong Kong is becoming more advanced in clinical research. On October 31, Hong Kong’s Pharmacy and Poisons Board was allocated “observer status” with the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use... Read More